Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Citation
Tobacco Deal-Breaker?
Newsletter
The Competitive Enterprise Institute Daily Update
1. HEALTH & SAFETY A Texas court case against the drug maker Merck & Co. over the safety of the painkiller Vioxx…
Op-Eds
Are We in a Brave New World of “Personalized” Medicine?
BiDil, a new drug labeled for treatment of blacks with severe heart failure, has begun to arrive in pharmacies. Approved by FDA in…
Op-Eds
More Crop for the Drop
The worst East Central U.S. drought in almost 20 years is decimating harvests of corn and soybeans, threatening farmers’ economic survival and disrupting commercial shipping…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. AGRICULTURE A severe drought hits corn growers in the Midwest. CEI Experts Available to Comment:…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. ENERGY CNN contrasts the current high gas prices in the U.S. with other nations…